Feb 12
|
Some May Be Optimistic About GSK's (LON:GSK) Earnings
|
Feb 11
|
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
|
Feb 10
|
Recent uptick might appease GSK plc (LON:GSK) institutional owners after losing 7.8% over the past year
|
Feb 6
|
Bear Of The Day: GSK PLC (GSK)
|
Feb 6
|
Kratos Defense and GSK have been highlighted as Zacks Bull and Bear of the Day
|
Feb 6
|
GSK PLC (GSK) Q4 2024 Earnings Call Highlights: Strong Specialty Medicines Drive Growth Amid ...
|
Feb 6
|
The most popular stocks and funds for investors in January
|
Feb 6
|
Why GSK plc (GSK) Went Up on Wednesday
|
Feb 5
|
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
|
Feb 5
|
GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan
|
Feb 5
|
Steady M&A Deals to Begin 2025, Disappointing IPOs So Far
|
Feb 5
|
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion
|
Feb 5
|
GSK lifts long-term sales targets on new drug pipeline
|
Feb 5
|
GSK (GSK) Tops Q4 Earnings and Revenue Estimates
|
Feb 5
|
GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares
|
Feb 5
|
Trending tickers: Alphabet, Advanced Micro Devices, PayPal, Novo Nordisk and GSK
|
Feb 5
|
FTSE 100 Live 05 February: GSK shares surge on new guidance, gold at record price
|
Feb 4
|
RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.
|
Jan 29
|
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline
|
Jan 29
|
GSK announces EMA accepted for review the MAA for depemokimab
|